Matthew N. Harris

Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine.

Jean‐Claude Bystryn, Anne Zeleniuch‐Jacquotte, Ruth Oratz et al. · PubMed · 2001 · 102 citations

Surgical Oncology, Immunology, Immunoediting +17

Immunogenicity of a polyvalent melanoma antigen vaccine in humans

Jean‐Claude Bystryn, Ruth Oratz, Matthew N. Harris et al. · Cancer · 1988 · 62 citations · Full text

Vaccination, Cancer Immunosurveillance, Allergy +13

Improved survival of patients with melanoma with an antibody response to immunization to a polyvalent melanoma vaccine

Kenneth E. Miller, Gwen Abeles, Ruth Oratz et al. · Cancer · 1995 · 61 citations

Changes in the presence of multiple markers of circulating melanoma cells correlate with clinical outcome in patients with melanoma.

Sandra R. Reynolds, J.K. Albrecht, Richard L. Shapiro et al. · PubMed · 2003 · 59 citations

Volume of Malignant Melanoma Is Superior to Thickness as a Prognostic Indicator

Robert J. Friedman, Darrell S. Rigel, Alfred W. Kopf et al. · Dermatologic Clinics · 1991 · 53 citations

Surgical Oncology, Medicine, Melanoma +8